UNIGE document Scientific Article
previous document  unige:19797  next document
add to browser collection
Title

Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide

Authors
Emamaullee, Juliet A.
Merani, Shaheed
Kin, Tatsuya
Al-Saif, Faisal
Truong, Wayne
Pawlick, Rena
Davis, Joy
show hidden authors show all authors [1 - 13]
Published in Endocrinology. 2009, vol. 150, no. 5, p. 2145-2152
Abstract Although insulin independence is maintained in most islet recipients at 1 yr after transplant, extended follow-up has revealed that many patients will eventually require insulin therapy. Previous studies have shown that islet autografts are prone to chronic failure in large animals and humans, suggesting that nonimmunological events contribute to islet graft functional decay. Early intervention with therapies that promote graft stability should provide a measurable benefit over time. In this study, the efficacy of the long-acting glucagon-like peptide-1 analog liraglutide was explored in a porcine marginal mass islet autograft transplant model. Incubation with liraglutide enhanced porcine islet survival and function after prolonged culture. Most vehicle-treated (83%) and liraglutide-treated (80%) animals became insulin independent after islet autotransplantation. Although liraglutide therapy did not improve insulin independence rates or blood glucose levels after transplant, a significant increase in insulin secretion and acute-phase insulin response was observed in treated animals. Surprisingly, no evidence for deterioration of graft function was observed in any of the transplanted animals over more than 18 months of follow-up despite significant weight gain; in fact, an enhanced response to glucose developed over time even in control animals. Histological analysis showed that intraportally transplanted islets remained highly insulin positive, retained alpha-cells, and did not form amyloid deposits. This study demonstrates that marginal mass porcine islet autografts have stable long-term function, even in the presence of an increasing metabolic demand. These results are discrepant with previous large animal studies and suggest that porcine islets may be resistant to metabolic failure.
Keywords AnimalsApoptosis/drug effectsCells, CulturedDose-Response Relationship, DrugFemaleGlucagon-Like Peptide 1/*analogs & derivatives/pharmacology/therapeutic useGlucose/metabolismGraft Survival/*drug effects/physiologyInsulin-Secreting Cells/drug effects/metabolism/physiology/transplantationIslets of Langerhans Transplantation/*methods/rehabilitation/veterinaryMetabolic Diseases/*prevention & controlSwineSwine, MiniatureTime FactorsTransplantation, Autologous
Identifiers
PMID: 19131571
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://endo.endojournals.org/content/150/5/2145.full.pdf
Structures
Research group Transplantation et hépatologie (905)
Citation
(ISO format)
EMAMAULLEE, Juliet A. et al. Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. In: Endocrinology, 2009, vol. 150, n° 5, p. 2145-2152. https://archive-ouverte.unige.ch/unige:19797

202 hits

0 download

Update

Deposited on : 2012-04-23

Export document
Format :
Citation style :